Bea Fertility

Bea Fertility

At home fertility treatment, at 1/10th the cost of IVF

Company
Bea Fertility
Category
Fertility, Femtech, Consumer
Portfolio
Fund 3
Date
2024

Bea Fertility has developed a hormone-free, intracervical insemination (ICI) applicator, which takes IVF-level fertility treatment out of the clinic, and allows consumers to maximise their chances of pregnancy at home, for less than 1/10th of the cost. 

The use of Bea’s cervical cap, which inserts sperm into the cervix, creates a 3.25x concentration of sperm near the uterus, and has so far achieved a 39.28% pregnancy rate across 3 treatment cycles – surpassing the chance of success of a first attempt of IVF (20%-35%). The device is readily accessible on the market (here) and has already resulted in at least 29 live births and counting as of June 2024.

Bea Fertility
Bea Fertility